These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 37127071)

  • 41. Improvement in Pulmonary Vascular Resistance After Relief of Fontan Circuit Obstruction.
    Yell J; Boyer PJ; Bernardi A; Klewer S; Seckeler MD
    J Invasive Cardiol; 2020 Oct; 32(10):E254-E257. PubMed ID: 32999096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of the acute pulmonary vasodilating effect of beraprost sodium and nitric oxide in congenital heart disease.
    Durongpisitkul K; Laoprasitiporn D; Layangool T; Sittiwankul R; Panamonta M; Mokrapong P;
    Circ J; 2005 Jan; 69(1):61-4. PubMed ID: 15635204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of lack of pulsatility on pulmonary endothelial function in the Fontan circulation.
    Henaine R; Vergnat M; Bacha EA; Baudet B; Lambert V; Belli E; Serraf A
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):522-9. PubMed ID: 23219498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension (CTEPH).
    Suntharalingam J; Hughes RJ; Goldsmith K; Doughty N; George P; Toshner M; Sheares KK; Pepke-Zaba J
    Vascul Pharmacol; 2007 Jun; 46(6):449-55. PubMed ID: 17368113
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension.
    Leuchte HH; Schwaiblmair M; Baumgartner RA; Neurohr CF; Kolbe T; Behr J
    Chest; 2004 Feb; 125(2):580-6. PubMed ID: 14769741
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance.
    Sablotzki A; Hentschel T; Gruenig E; Schubert S; Friedrich I; Mühling J; Dehne MG; Czeslick E
    Eur J Cardiothorac Surg; 2002 Nov; 22(5):746-52. PubMed ID: 12414041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response to inhaled nitric oxide in patients with acute right heart syndrome.
    Bhorade S; Christenson J; O'connor M; Lavoie A; Pohlman A; Hall JB
    Am J Respir Crit Care Med; 1999 Feb; 159(2):571-9. PubMed ID: 9927375
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhaled nitric oxide versus sodium nitroprusside for preoperative evaluation of pulmonary hypertension in heart transplant candidates.
    Pasero D; Rana NK; Bonato R; Ribezzo M; Ivaldi F; Ricci D; Grosso Marra W; Checco L; Lupo M; Boffini M; Rinaldi M
    Transplant Proc; 2013 Sep; 45(7):2746-9. PubMed ID: 24034038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Direct comparison of the effects of nebulized nitroprusside versus inhaled nitric oxide on pulmonary and systemic hemodynamics during hypoxia-induced pulmonary hypertension in piglets.
    Schreiber MD; Dixit R; Rudinsky B; Hipps R; Morgan SE; Keith RRT A; Meadow W
    Crit Care Med; 2002 Nov; 30(11):2560-5. PubMed ID: 12441770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Inhaled nitric oxide in the peroperative period and recovery].
    Robin E; Haddad E; Vallet B
    Ann Fr Anesth Reanim; 2002 Jul; 21(7):581-90. PubMed ID: 12192691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination of intravenously infused methylene blue and inhaled nitric oxide ameliorates endotoxin-induced lung injury in awake sheep.
    Kirov MY; Evgenov OV; Bjertnaes LJ
    Crit Care Med; 2003 Jan; 31(1):179-86. PubMed ID: 12545013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension.
    Preston IR; Klinger JR; Landzberg MJ; Houtchens J; Nelson D; Hill NS
    Chest; 2001 Sep; 120(3):866-72. PubMed ID: 11555522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiac surgery and inhaled nitric oxide: indication and follow-up (2-4 years).
    Yahagi N; Kumon K; Tanigami H; Watanabe Y; Haruna M; Hayashi H; Imanaka H; Takeuchi M; Takamoto S
    Artif Organs; 1998 Oct; 22(10):886-91. PubMed ID: 9790088
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Left ventricular chamber function during inhaled nitric oxide in patients with dilated cardiomyopathy.
    Hayward CS; Kalnins WV; Rogers P; Feneley MP; Macdonald PS; Kelly RP
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):749-54. PubMed ID: 10547093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Residual pulmonary vasoreactivity to inhaled nitric oxide in patients with severe obstructive pulmonary hypertension and Eisenmenger syndrome.
    Budts W; Van Pelt N; Gillyns H; Gewillig M; Van De Werf F; Janssens S
    Heart; 2001 Nov; 86(5):553-8. PubMed ID: 11602551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhaled nitric oxide in patients with cystic fibrosis during preoperative evaluation and during anaesthesia for lung transplantation.
    Della Rocca G; Coccia C; Pugliese F; Pompei L; Ruberto F; Venuta F; Rendina EA; Coloni GF; Ricci C; Gasparetto A
    Eur J Pediatr Surg; 1998 Oct; 8(5):262-7. PubMed ID: 9825234
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Maturational changes in ovine pulmonary vascular responses to inhaled nitric oxide.
    Powel V; Moreira GA; O'Donnell DC; Filippov G; Bloch KD; Gordon JB
    Pediatr Pulmonol; 1999 Mar; 27(3):157-66. PubMed ID: 10213253
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute right heart failure after hemorrhagic shock and trauma pneumonectomy-a management approach: A blinded randomized controlled animal trial using inhaled nitric oxide.
    Lubitz AL; Sjoholm LO; Goldberg A; Pathak A; Santora T; Sharp TE; Wallner M; Berretta RM; Poole LA; Wu J; Wolfson MR
    J Trauma Acute Care Surg; 2017 Feb; 82(2):243-251. PubMed ID: 28107308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.
    Lepore JJ; Maroo A; Bigatello LM; Dec GW; Zapol WM; Bloch KD; Semigran MJ
    Chest; 2005 May; 127(5):1647-53. PubMed ID: 15888841
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy of nitroglycerin inhalation in reducing pulmonary arterial hypertension in children with congenital heart disease.
    Goyal P; Kiran U; Chauhan S; Juneja R; Choudhary M
    Br J Anaesth; 2006 Aug; 97(2):208-14. PubMed ID: 16707530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.